Journal of Neuro-Oncology

Article	Citations
Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma	63
Factors influencing timely diagnosis in neurolymphomatosis	50
Preoperative meningioma vascularity index is associated with significantly increased intraoperative blood loss and greater risk of subtotal resection	49
Variables associated with 90-day readmission following craniotomy for tumor in the pediatric population	43
A practical guide to neuro-oncology fellowship	42
Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma	41
Prognostic factors among patients with brain metastases from cancer of unknown primary site	40
Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence	39
Letter: Exploring cell-free DNA as a biomarker for assessing tumor burden in metastatic spine disease	39
Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study	38
Different clinical and cytogenetic features of primary skull base meningiomas and non-skull base meningiomas	37
Predictors of brain metastases in patients with oligometastatic solid tumours treated with stereotactic body radiation therapy	36
Congress of Neurological Surgeons systematic review and evidence‑based guidelines on the management of recurrent diffuse low-grade glioma: update	33
Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort stu	32
Elevated baseline C-reactive protein levels predict poor progression-free survival in sporadic vestibular schwannoma	31
Efficacy of endoscopic management of primary central nervous system lymphoma: a multicentric study and literature review	29
Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis	29
Two is better than one: longitudinal detection and volumetric evaluation of brain metastases after Stereotactic Radiosurgery with a deep learning pipeline	29
Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis	29
Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor	29
The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management	28
MR susceptibility imaging for detection of tumor-associated macrophages in glioblastoma	28
Same but different. Incidental and symptomatic lower grade gliomas show differences in molecular features and survival	28
Panobinostat in adults with H3 K27M-mutant diffuse midline glioma: a single-center experience	28
Whole Body-MRI assessment of peripheral lesions in patients with NF2-related schwannomatosis on systemic bevacizumab	27

Repeated responders to bevacizumab combination treatment in recurrent glioblastoma: a retrospective case study	27
Complete resolution of peritumoral FLAIR hyperintensity is infrequent in surgically treated patients with intracranial meningiomas	27
Relevant pharmacologic interactions in the concurrent management of brain tumor-related epilepsy and venous thromboembolism: a systematic review	27
Distinct size and spatial distribution patterns of ALK-inhibitor-naïve versus ALK-inhibitor exposed ALK-positive NSCLC brain metastases	27
Immune-related aseptic meningitis and strategies to manage immune checkpoint inhibitor therapy: a systematic review	26
Differentiating radiation necrosis from tumor recurrence: a systematic review and diagnostic meta-analysis comparing imaging modalities	26
Focused versus conventional radiotherapy in spinal oncology: is there any difference in fusion rates and pseudoarthrosis?	25
The trial effect in patients with glioblastoma: effect of clinical trial enrollment on overall survival	25
Whole exome sequencing study of adamantinomatous craniopharyngioma reveals the mutational characteristics of recurrent cases	24
Journal of Neuro-Oncology, Meningioma issue	24
Development of a recursive partitioning analysis for prediction of radiation necrosis following single-fraction stereotactic radiosurgery for intact brain metastases	24
Glioblastoma cell motility and invasion is regulated by membrane-associated heat shock protein Hsp70	24
Predicting post-surgical functional status in high-grade glioma with resting state fMRI and machine learning	23
Patterns and predictors of anxiety and depression symptom trajectories in patients diagnosed with primary brain tumors	23
Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice	23
Incidence, molecular characteristics, and imaging features of “clinically-defined pseudoprogression” in newly diagnosed glioblastoma treated with chemoradiation	22
First-in-human sonodynamic therapy with ALA for pediatric diffuse intrinsic pontine glioma: a phase 1/2 study using low-intensity focused ultrasound	22
Early and late structural brain changes after radiation therapy: an MRI study in glioma patients	21
Chemotherapy is an efficient treatment in primary CNS MALT lymphoma	21
Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses	20
Correction to: MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44	20
Prevalence, therapeutic approaches, and survival rates of brain metastases in non-small cell lung cancer: a multi-institutional claims-based study from 2014 to 2024	20
Procedural volume is linearly associated with mortality, major complications, and readmissions in patients undergoing malignant brain tumor resection	20
Local control outcomes for combination of stereotactic radiosurgery and immunotherapy for non-small cell lung cancer brain metastases	20
The role of spine stereotactic radiosurgery for patients with breast cancer metastases	20
Patterns of treatment and outcomes of patients with brain-only metastatic breast cancer	20
The evolving role of reirradiation in the management of recurrent brain tumors	20
Brain metastases from ovarian cancer: neuroradiological profile and survival overview of neurosurgical cases	20
Correction to: Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme	19
Surgical strategies for older patients with glioblastoma	19
Postoperative CT scans after resection of brain metastases: neurosurgical routine or added value?	19
Neuroradiological features of patients with bilateral macronodular adrenocortical disease and meningiomas associated or not with genetic variants of ARMC5– a case series	19
Correction to: Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data	19
Integration of molecular pathology with histopathology to accurately evaluate the biological behaviour of WHO grade 2 meningiomas and patient prognosis	19
Incidence, management, and outcome of incidental meningioma: what has happened in 10 years?	19
Bevacizumab in recurrent glioblastoma: does dose matter? Our monocentric and comparative experience	18
Quality indicators in neuro-oncology: Review of the literature and development of a new quality indicator set for glioma care through a two-round Delphi survey	18
Patterns of response following gamma knife radiosurgery for tectal plate gliomas	18
The utility of long-term methylphenidate in preserving intellectual development in survivors of childhood brain tumour	18
The concept, intention, and evaluation of the term treatment-refractory meningioma	18
The use of telemedicine in pre-surgical evaluation: a retrospective cohort study of a neurosurgical oncology practice	18
Intrathecal anti-PD-1 treatment in metastatic melanoma patients with leptomeningeal disease (LMD): real-world data and evidence	18
Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy	18
Raman and autofluorescence spectroscopy for in situ identification of neoplastic tissue during surgical treatment of brain tumors	18
Correction to: A prospective study of minimally invasive keyhole craniotomy and stereotactic brachytherapy for new brain oligometastases	18
Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients	18
Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression	17
Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches	17
Management and treatment of brain tumors during pregnancy: an Italian survey	17
Real-world cost- effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China	17

Letter to the editor: the impact of systemic treatment on brain metastases should be considered in clinical outcome analysis	17
Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control	17
AANS/CNS Endorsement	17
Genetic predictors of neurocognitive outcomes in survivors of pediatric brain tumors	16
The posterior fossa syndrome questionnaire: using science to inform practice	16
Ciprofol reduces postoperative glioma recurrence by promoting MAPK11-PML phosphorylation: insights from transcriptomic and proteomic analysis	16
Comment on “The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management”	16
IDH1 mutation is associated with improved resection rates, progression-free survival and overall survival in patients with anaplastic astrocytomas	16
The role of cesium-131 brachytherapy in brain tumors: a scoping review of the literature and ongoing clinical trials	16
NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates NOTCH1-WNT5A signaling with stem cell maintenance and angiogenesis	16
Genome-wide association study on meningioma risk in Japan: a multicenter prospective study	16
Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis	16
Pre-treatment systemic inflammation response index and systemic immune inflammation in patients with primary central nerve system lymphoma as a useful prognostic indicator	16
The state of art of awake craniotomy in Latin American countries: a scoping review	16
The Journal of Neuro-Oncology: the last and next 40 years	16
Radiotherapeutic advances in the management of glioblastoma	16
Is H3 K27M mutation testing relevant in the diagnostic routine of WHO grade 4 gliomas exclusively located in the corpus callosum in adults?	16
Junctional adhesion molecular 3 (JAM3) is a novel tumor suppressor and improves the prognosis in breast cancer brain metastases via the TGF-β/Smad signal pathway	16
Stereotactic radiosurgery ensures an effective and safe long-term control of Koos grade IV vestibular schwannomas: a single-center, retrospective, cohort study	16
Risk calculator for long-term survival prediction of spinal chordoma versus chondrosarcoma: a nationwide analysis	16
Repurposing mebendazole against triple-negative breast cancer CNS metastasis	16
Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of chemotherapy in newly diagnosed WHO Grade II diffuse glioma in adults: update	15
Anatomical and surgical characteristics correlate with pachymeningeal failure in patients with brain metastases after neurosurgical resection and adjuvant stereotactic radiosurgery	15
High dose image-guided, intensity modulated radiation therapy (IG-IMRT) for chordomas of the sacrum, mobile spine and skull base: preliminary outcomes	15
Thalamic gliomas in adults: a systematic review of clinical characteristics, treatment strategies, and survival outcomes	15
Diagnostic value of 18F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients	15
Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT	15
Stereotactic radiosurgery for patients with spinal metastases from prostate cancer	15
Initial results of a phase II trial of 18F-DOPA PET-guided re-irradiation for recurrent high-grade glioma	15
Comparative efficacy and safety of sodium fluorescein-guided surgery versus standard white light for resection of brain metastases: a systematic review and meta-analysis	15
Letter to the editor: surgeon experience in glioblastoma surgery of the elderly—a multicenter, retrospective cohort study	15
Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma	15
Preoperative assessment of eloquence in neurosurgery: a systematic review	15
Seizure outcomes after resection of primary brain tumors in pediatric patients: a systematic review and meta-analysis	15
Reirradiation versus systemic therapy versus combination therapy for recurrent high-grade glioma: a systematic review and meta-analysis of survival and toxicity	15
Histopathological correlation of brain tumor recurrence vs. radiation effect post-radiosurgery as detected by MRI contrast clearance analysis: a validation study	14
Outcomes of radiation-induced meningiomas treated with stereotactic radiosurgery	14
Anatomical changes in resection cavity during brain radiotherapy	14
Single nCounter assay for prediction of MYCN amplification and molecular classification of medulloblastomas: a multicentric study	14
Outcomes following radiation therapy for embryonal tumor with multilayered rosettes (ETMR): results from the Pediatric Proton/Photon Consortium Registry (PPCR)	14
The diagnostic efficiency of integration of 2HG MRS and IVIM versus individual parameters for predicting IDH mutation status in gliomas in clinical scenarios: A retrospective study	14
The 4S of spinal astrocytoma: specific location, syrinx, spasticity and score on Modified Mccormick Scale (MMS) predict long term outcomes in patients undergoing surgical resection of intramedullary s	14
Stereotactic radiosurgery for IDH wild type glioblastoma: an international, multicenter study	14
Transcranial magnetic stimulation for post-operative neurorehabilitation in neuro-oncology: a review of the literature and future directions	14
Elevating the findings by substituting in “ISarcoPRM”	14
High-dose furmonertinib combined with intraventricular chemotherapy as salvage therapy for leptomeningeal metastasis from EGFR exon 20 insertion-mutated lung cancer	14
The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine glioma tissues	14
Phase I study targeting newly diagnosed grade 4 astrocytoma with bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomide	14
Targeting ataxia-telangiectasia mutated and cystine/glutamate antiporter enhances radiotherapy efficacy and tumor suppression in glioblastoma	13
Roles and outcomes of stereotactic biopsy for adult patients with brainstem lesion	13
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104	13
NUDT21 alters glioma migration through differential alternative polyadenylation of LAMC1	13
Postoperative stereotactic radiosurgery for intracranial solitary fibrous tumors: systematic review and pooled quantitative analysis	13
CAR-engineered NK cells versus CAR T cells in treatment of glioblastoma; strength and flaws	13
The role of MRI patterns in predicting neurologic deficits in spinal ependymomas	13
Correction to: Transcranial magnetic stimulation for post-operative neurorehabilitation in neuro-oncology: a review of the literature and future directions	13
Cystic glioblastoma IDH-wildtype: genetic alterations and outcomes	13
Targeting COL5A1 enhances anoikis thus attenuating malignancy of glioblastoma via inhibiting the Wnt/β-catenin signaling pathway	13
The prognostic significance of HIST1H3B/C and H3F3A K27M mutations in diffuse midline gliomas is influenced by patient age	13
Standardizing connectome-based brain tumor surgery through a network-based surgical nomenclature	13
Impact of proton versus photon radiotherapy on overall survival in the management of spinal chordoma and mortality risk prediction: a nationwide analysis	13
ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449	13
Evaluating the role of gross total resection in primary spinal cord glioblastoma: evidence from a multicenter cohort and meta-analysis	13
Factors associated with cognitive impairment in long-term IDH-mutant glioma survivors	13
Study of prediction model for high-grade meningioma using fractal geometry combined with radiological features	13
Palliative care of older glioblastoma patients in neurosurgery	13
Correction to: Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review	12
Clinical and radiographic characteristics of diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma: a single institution review	12
Management of chordoma and chondrosarcoma with definitive dose-escalated single-fraction spine stereotactic radiosurgery	12
Large vestibular schwannoma treated using a cranial nerve sparing approach with planned subtotal microsurgical resection and stereotactic radiosurgery: meta-analysis and International Stereotactic Rad	12
Long-term outcomes of central neurocytoma – an institutional experience	12
Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysis	12
Computerized assessment of neuropsychological functioning in pediatric brain tumor patients	12
Racial disparities in the management and outcomes of primary osseous neoplasms of the spine: a SEER analysis	12
Correction to: The characteristics of brain structural remodeling in patients with unilateral vestibular schwannoma	12
Patient-derived glioma organoids real time identification of IDH mutation, 1p/19q-codeletion and CDKN2A/B homozygous deletion with differential ion mobility spectrometry	12
An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma	12
The role of irinotecan-bevacizumab as rescue regimen in children with low-grade gliomas: a retrospective nationwide study in 72 patients	12
Exploring the prognostic value of BRMS1 + microglia based on single-cell anoikis regulator patterns in the immunologic microenvironment of GBM	12
Surgeon experience in glioblastoma surgery of the elderly—a multicenter, retrospective cohort study	12

Advanced imaging characterization of post-chemoradiation glioblastoma stratified by diffusion MRI phenotypes known to predict favorable anti-VEGF response	12
Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions	12
Superficial meningioma with bone involvement: surgical strategies and clinical outcomes	12
Hematological adverse events in the management of glioblastoma	12
Neuropsychological impairment in primary malignant brain tumor patients with awake craniotomy: a hospital-based registration study	12
Advanced imaging reveals enhanced malignancy in glioblastomas involving the subventricular zone: evidence of increased infiltrative growth and perfusion	12
ERK inhibition in glioblastoma is associated with autophagy activation and tumorigenesis suppression	12
Preoperative frailty measured by risk analysis index predicts complications and poor discharge outcomes after Brain Tumor Resection in a large multi-center analysis	12
Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial	12
Tissue biopsy before resection in glioblastoma: is there an opportunity to improve outcomes with liquid biopsies and pre-operative stereotactic radiosurgery?	12
Impact of seizures and antiseizure medication on survival in patients with glioma	11
The patients’ experience of neuroimaging of primary brain tumors: a cross-sectional survey study	11
Comment on “Amino-acid PET as a prognostic tool after post-stupp protocol temozolomide therapy in high-grade glioma patients”	11
Stereotactic body radiation therapy for spinal metastases from gastrointestinal primary cancers	11
Perilesional resection technique of glioblastoma: intraoperative ultrasound and histological findings of the resection borders in a single center experience	11
Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol	11
Gamma knife radiosurgery for breast cancer brain metastasis: survival outcomes, prognotic factors, and the role of repeat treatment	11
Resection of craniopharyngiomas: comparison between gross total resection and subtotal resection with adjuvant radiation	11
Particle beam radiotherapy in the treatment of WHO grade 2 and 3 meningiomas: an early experience from Shanghai Proton and Heavy Ion Center	11
DNA damage in IDH-mutant gliomas: mechanisms and clinical implications	11
IDH1 p.R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomas	11
Evaluation of clinical and volumetric outcomes following adaptive gamma knife radiosurgery for brain metastases	11
Likelihood-of-harm/help of microsurgery compared to radiosurgery in large vestibular schwannoma	11
High-grade glioma imaging volumes and survival: a single-institution analysis of 101 patients after resection using intraoperative MRI	11
Efficacy and safety of immune checkpoint inhibitors plus anlotinib in small cell lung cancer with brain metastases: a retrospective, multicentre study	11
Additive risk of surgical site infection from more than one risk factor following craniotomy for tumor	11
Study of Strawberry Notch homolog 1 and 2 expression in human glioblastoma	11
Multimodal treatment of glioblastoma with multiple lesions - a multi-center retrospective analysis	11
Long-term outcomes of fractionated proton beam therapy for benign or radiographic intracranial meningioma	11
The association of hospital volume status with treatment and survival outcomes of intracranial meningioma patients: a multivariable analysis of the National Cancer Database	11
Meningioma in patients exposed to progestin drugs: results from a real-life screening program	11
Repeated stereotactic radiosurgery for high grade meningioma	11
Expression of ABCB1, ABCC1 and 3 and ABCG2 in glioblastoma and their relevance in relation to clinical survival surrogates	10
Impact of the COVID-19 pandemic on neuro-oncology outcomes	10
Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk–benefit analysis	10
Validation of the initial brain metastasis velocity in non-small cell lung cancer at a single cancer center	10
Tumor-related epilepsy in high-grade glioma: a large series survival analysis	10
Treatment outcomes for response-based radiotherapy in children and adolescents with central nervous system germinoma: a prospective study	10
Correction to: Tumor location-based classification of surgery-related language impairments in patients with glioma	10
Primary CNS lymphoma of the corpus callosum: presentation and neurocognitive outcomes	10
Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study	10
MGMT promoter methylation in 1p19q-intact gliomas	10
Frequency of and risk factors associated with local recurrence after spinal stereotactic body radiation therapy without surgery	10
Short-term sensorimotor training incorporating cognitive tasks for pediatric survivors of posterior fossa tumors: a pilot study	10
Interstitial photodynamic therapy for newly diagnosed glioblastoma	10
Bevacizumab plus irinotecan with or without gamma knife radiosurgery after failure of concurrent chemo-radiotherapy for high-grade glioma	10
Identification of a high-risk group for brain metastases in non-small cell lung cancer patients	10
Physical function, body mass index, and fitness outcomes in children, adolescents, and emerging adults with craniopharyngioma from proton therapy through five years of follow-up	10
Clinical and neuropathological criteria for distinguishing between IDH-mutant astrocytomas of WHO grade 2 and 3	10
Correction to: Umbrella review and network meta-analysis of diagnostic imaging test accuracy studies in differentiating between brain tumor progression versus pseudoprogression and radionecrosis	10
Clinical Course after Carmustine Wafer Implantation for Newly Diagnosed Adult-type Diffuse Gliomas; A controlled propensity matched analysis of a single center cohort	10
Demographic variations and time to initiation of adjunct treatment following surgical resection of anaplastic astrocytoma in the United States: a National Cancer Database analysis	10
Pharmaceutical equivalent 5-aminolevulinic acid fluorescence guided resection of central nervous system tumors: feasibility, safeness and cost-benefit considerations	10
Is reduced-dose whole-brain radiotherapy also feasible in primary CNS lymphoma for curative or salvage purpose?	10
Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study	10
Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification	10
T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma	10
Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients	10
Does preoperative gamma knife treatment affect the result of microresection of vestibular schwannoma?	10
The cognitive functions and seizure outcomes of patients with low-grade epilepsy-associated neuroepithelial tumors	10
Regression of sporadic CNS hemangioblastomas with belzutifan	10
Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis	9
Correction to: Early EEG hyperexcitability is associated with decreased survival in newly diagnosed IDH-wildtype glioma	9
Optimizing reirradiation for relapsed medulloblastoma: identifying the ideal patient and tumor profiles	9
Breast cancer brain metastases localization and risk of hydrocephalus: a single institution experience	9
Neurocognitive and radiological follow-up of children under 5 years of age treated for medulloblastoma according to the HIT-SKK protocol	9
Systemic coagulation is activated in patients with meningioma and glioblastoma	9
Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastoma	9
Stereotactic radiosurgery for brain metastases: evolving practice patterns from the national cancer database (2004–2020)	9
Effect of distance from target on hypopituitarism after stereotactic radiosurgery for pituitary adenomas	9
Epidemiology of WHO grade 2 and grade 3 gliomas from 2009 to 2021 in Germany	9
Peritumoral edema resolves infrequently in surgically treated patients with intracranial meningioma– a retrospective study of 279 meningioma patients	9
Impact of brain metastasis size at the time of radiotherapy on local control and radiation necrosis	9
Overexpression of LSR suppresses glioma proliferation and invasion via regulating FOXO3a	9
Magnetic resonance imaging signal characteristics associated with prognosis of skull base chordoma after gamma knife radiosurgery	9
The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors	9
Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies	9
Association between tumor location and toxicity outcomes after stereotactic radiosurgery for brain metastases	9
Stereotactic radiosurgery for brain metastases from human epidermal receptor 2 positive breast Cancer: an international, multi-center study	9
Long-term quality of life and hypothalamic dysfunction after craniopharyngioma	9
Collagen type I alpha 1 induces radio-resistance in hypoxic glioblastoma cells by promoting autophagy	9
Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review	9
The “Combo” radiotherapy treatment for high-risk grade 2 meningiomas: dose escalation and initial safety and efficacy analysis	9
Non-navigated 2D intraoperative ultrasound: An unsophisticated surgical tool to achieve high standards of care in glioma surgery	9
Mental health status and associated factors of caregivers of patients with malignant brain tumors	9
Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience	9
Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis	9
Comparative analysis of hypofractionated short-course versus standard radiation therapy in elderly patients with glioblastoma: analysis of nationwide database	9
Glioblastomas at the white matter of temporo-parietal junction cause a poor postoperative independence level	9
Standard or extended STUPP? Optimal duration of temozolomide for patients with high-grade gliomas: a retrospective analysis	9
The role of GammaTile in the treatment of brain tumors: a technical and clinical overview	9
Multisession radiosurgery for grade 2 (WHO), high risk meningiomas. A phase II clinical trial	9
Financial toxicity in patients with glioblastoma	9
Postoperative epilepsy and survival in glioma patients: a nationwide population-based cohort study from 2009 to 2018	9
Application of 5T glutamate chemical exchange saturation transfer imaging in brain tumors: preliminary results	9